zen-3694, a novel bet inhibitor, in tnbc without germline brca1/2 mutations
Published 2 years ago • 124 plays • Length 3:39Download video MP4
Download video MP3
Similar videos
-
1:13
opportunities for novel targets or therapies in tnbc
-
0:57
treating brca1 and brca2 breast cancer
-
0:19
the hidden threat of triple negative breast cancer: a critical link with brca mutations
-
1:28
recent developments in treating tnbc with targeted therapies
-
7:42
the complexities of battling triple-negative breast cancer
-
12:38
triple-negative breast cancer: everything you need to know
-
8:37
brca1 and brca2 mutations & cancer (types of cancer, and who’s most at risk)
-
1:58
promising novel approaches to the treatment of tnbc
-
1:12
novel immune checkpoint inhibitor combinations for tnbc treatment
-
1:48
residual tumor treatment in mutant brca-1 triple-negative breast cancer
-
0:41
the importance of brca-1 testing in triple negative breast cancer
-
0:10
finished chemo and still don't feel like yourself
-
2:01
ascent: sacituzumab govitecan outperforms chemo in black patients with tnbc
-
0:13
chemo #breastcancer #tnbc #chemotherapy #chemo #breastcancersurvivor #cancerjourney #cancer #fyp
-
0:16
red devil #reddevil #tnbc #triplenegativebreastcancer #breastcancerawareness #cancerwarrior #fyp
-
4:23
swog s1416: cisplatin /- veliparib in tnbc
-
2:07
tnbc: using checkpoint inhibitors alone or with chemotherapy
-
1:14
the importance of a biomarker-directed approach in triple-negative breast cancer
-
2:05
treatment advances in tnbc
-
0:15
3 year cancer survivor - stage 4 breast cancer at 22 #shorts
-
1:16
dr. tolaney on platinum-based therapy in neoadjuvant setting of tnbc
-
1:00
triple negative breast cancer - dr tasha #shorts #breastcancer #breastcancerawareness #drtasha